# Metagenomi Therapeutics, Inc.: Form 8-K, filed Feb 13, 2024

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: 8-K
- Filed: 2024-02-13
- Accepted by EDGAR: Feb 13, 2024, 16:06 ET
- Period: 2024-02-13
- Accession: 0001193125-24-033697
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000119312524033697/d770467d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000119312524033697/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000119312524033697/d770467d8k.htm

Filed Feb 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-033697. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.